Hypoglycemic 5-substituted oxazolidine-2,4-diones

Details Hypoglycemic 5-substituted oxazolidine-2,4-diones Hypoglycemic 5-substituted oxazolidine-2,4-diones

1981-01-02

1983-01-04

Sutto, Anton H.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

548226, 544299, 544305, 568308, C07D26344, A61K 3142

Patent

active

043672345

ABSTRACT:
Hypoglycemic 5-phenyl and 5-naphthyl oxazolidine-2,4-diones and the pharmaceutically-acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.

REFERENCES:
patent: 2338220 (1944-01-01), Wallingford
patent: 2721197 (1955-10-01), Sheehan
patent: 3699229 (1972-10-01), Plotnikoff
patent: 4220787 (1980-09-01), Scholz
Najer et al., Bull. Soc. Chim, France, pp. 1226-1230, 1231-1238, (1961): Chem. Abstracts 55, Cols. 27268-27269 (1961).
Burger, Medicinal Chemistry, 2nd Ed., p. 43, 1960.
Ciamacian and Silber, Ber. 19, pp. 1708-1714, (1886).
Clark-Lewis, Chem. Rev. 58, pp. 63-99, (1958).
Brink and Freeman, J. Neuro, Chem. 19, (7), pp. 1783-1788, (1972).
King and Clark-Lewis, J. Chem. Soc., pp. 3077-3079, (1961).
Reibsomer et al., J. Am. Chem. Soc. 61, pp. 3491-3493, (1939).

Affiliated with

Also associated with

Rating

Hypoglycemic 5-substituted oxazolidine-2,4-diones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hypoglycemic 5-substituted oxazolidine-2,4-diones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic 5-substituted oxazolidine-2,4-diones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1581704